Call: +91 8766 590 1366   |   [email protected]

Total $0
View Cart Checkout
Total $0
View Cart Checkout

Grab 20% OFF on all Premium Reports*
product image

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Research Report 2026

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Research Report 2026

Pages: 210

Format: PDF

Date: 01-2026

Request Sample   Request Customization
Category: Chemicals & Materials

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Report

Market Overview

The 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) is designed to prevent infections caused by pneumococcal bacteria, covering 23 of the most common serotypes. It is recommended for adults and children aged two years and older, while infants under two typically receive conjugate vaccines such as PCV7 or PCV13.

North America leads global production and consumption, accounting for nearly 70% of production share and 28% of sales share in 2015. Europe follows with 15% production and 20% sales share, while China holds 10% production and 15% sales share. The global PPSV23 market was valued at USD 1.55 billion in 2017 and is projected to reach USD 4.55 billion by 2025, growing at a CAGR of 14.4%.

Key Players

  • MSD (Merck & Co.)
  • Sanofi Pasteur
  • China National Biotec Group (CDIBP)
  • Pfizer Inc.
  • GlaxoSmithKline (GSK)
  • Seqirus (CSL Limited)
  • Serum Institute of India
  • Panacea Biotec
  • Shenzhen Kangtai Biological Products
  • Walvax Biotechnology
  • Bharat Biotech
  • Emergent BioSolutions

Market Segmentation

By Product Type

  • Single Dose Vial
  • Pre-filled Syringe

By Application

  • Children (2–10 years)
  • Adults (10–64 years)
  • Elderly (65+ years)

By Distribution Channel

  • Hospitals & Clinics
  • Public Health Programs
  • Pharmacies
  • Online Healthcare Platforms

By Region

  • North America
  • Europe
  • Asia-Pacific (China, India, Japan, South Korea, Australia, Southeast Asia)
  • Middle East & Africa
  • Central & South America

Regional Analysis

  • North America: Largest production hub, driven by Merck’s PPSV23 and strong immunization programs.
  • Europe: Sanofi Pasteur and GSK lead; demand supported by aging populations and government vaccination initiatives.
  • Asia-Pacific: China and India show rapid growth due to expanding healthcare infrastructure and government immunization drives.
  • South America: Brazil and Argentina are emerging markets with increasing vaccination coverage.
  • Middle East & Africa: Growth driven by WHO and UNICEF-supported immunization programs.

Porter’s Five Forces

  1. Threat of New Entrants – Low (high R&D costs, regulatory barriers).
  2. Bargaining Power of Suppliers – Moderate (specialized raw materials and biotech processes).
  3. Bargaining Power of Buyers – High (governments and health organizations negotiate bulk purchases).
  4. Threat of Substitutes – Moderate (conjugate vaccines like PCV13 compete in certain age groups).
  5. Industry Rivalry – High (few global players, intense competition in pricing and distribution).

SWOT Analysis

Strengths

  • Broad coverage against 23 pneumococcal strains
  • Strong demand from aging populations
  • Established global immunization programs

Weaknesses

  • Limited efficacy in children under 2 years
  • High production and distribution costs
  • Dependence on government procurement

Opportunities

  • Expansion in emerging markets with low vaccination coverage
  • Development of combination vaccines
  • Rising awareness of pneumococcal disease prevention

Threats

  • Competition from conjugate vaccines (PCV13, PCV15, PCV20)
  • Stringent regulatory requirements
  • Supply chain disruptions in global health crises

Trend Analysis

  • Increasing adoption of adult vaccination programs in developed markets.
  • Expansion of government-funded immunization initiatives in Asia and Africa.
  • Rising competition from next-generation conjugate vaccines.
  • Growth in pre-filled syringe formats for ease of administration.
  • Strategic collaborations between global pharma and local biotech firms.

Drivers & Challenges

Drivers

  • Rising incidence of pneumococcal infections globally
  • Aging populations requiring preventive care
  • Strong government and NGO support for vaccination programs
  • Technological advancements in vaccine delivery

Challenges

  • Competition from conjugate vaccines with broader age coverage
  • High R&D and regulatory compliance costs
  • Uneven healthcare infrastructure in developing regions
  • Vaccine hesitancy in certain populations

Value Chain Analysis

  1. Raw Material Supply – Biotech inputs and specialized reagents.
  2. Manufacturing – Vaccine formulation, filling, and packaging.
  3. Distribution – Hospitals, clinics, pharmacies, and public health programs.
  4. End Users – Children (2+), adults, elderly populations.

Quick Recommendations for Stakeholders

  • Manufacturers: Invest in next-generation formulations and expand pre-filled syringe offerings.
  • Investors: Focus on Asia-Pacific and Africa for high growth potential.
  • Policy Makers: Strengthen immunization programs and subsidize vaccine access.
  • Healthcare Providers: Promote adult vaccination awareness and improve distribution logistics.
  • Supply Chain Partners: Build resilience against global health crises and ensure cold-chain integrity.

 

Table of Contents

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Professional Survey Report
1 Industry Overview of 23-Valent Pneumococcal Polysaccharide Vaccine
    1.1 Definition and Specifications of 23-Valent Pneumococcal Polysaccharide Vaccine
        1.1.1 Definition of 23-Valent Pneumococcal Polysaccharide Vaccine
        1.1.2 Specifications of 23-Valent Pneumococcal Polysaccharide Vaccine
    1.2 Classification of 23-Valent Pneumococcal Polysaccharide Vaccine
        1.2.1 Single Dose Vial
        1.2.2 Pre-filled Syringe
    1.3 Applications of 23-Valent Pneumococcal Polysaccharide Vaccine
        1.3.1 For Children (2-10)
        1.3.2 For Person (10-64)
        1.3.3 For The Old (?65)
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 Europe
        1.4.3 China
        1.4.4 Japan
        1.4.5 Southeast Asia
        1.4.6 India

2 Manufacturing Cost Structure Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
    2.3 Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
    2.4 Industry Chain Structure of 23-Valent Pneumococcal Polysaccharide Vaccine

3 Technical Data and Manufacturing Plants Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
    3.1 Capacity and Commercial Production Date of Global 23-Valent Pneumococcal Polysaccharide Vaccine Major Manufacturers in
    3.2 Manufacturing Plants Distribution of Global 23-Valent Pneumococcal Polysaccharide Vaccine Major Manufacturers in
    3.3 R&D Status and Technology Source of Global 23-Valent Pneumococcal Polysaccharide Vaccine Major Manufacturers in
    3.4 Raw Materials Sources Analysis of Global 23-Valent Pneumococcal Polysaccharide Vaccine Major Manufacturers in

4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Overall Market Overview
    4.1 -E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 -E Global 23-Valent Pneumococcal Polysaccharide Vaccine Capacity and Growth Rate Analysis
        4.2.2  23-Valent Pneumococcal Polysaccharide Vaccine Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 -E Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate Analysis
        4.3.2  23-Valent Pneumococcal Polysaccharide Vaccine Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 -E Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Price
        4.4.2  23-Valent Pneumococcal Polysaccharide Vaccine Sales Price Analysis (Company Segment)

5 23-Valent Pneumococcal Polysaccharide Vaccine Regional Market Analysis
    5.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Analysis
        5.1.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Overview
        5.1.2 North America -E 23-Valent Pneumococcal Polysaccharide Vaccine Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America -E 23-Valent Pneumococcal Polysaccharide Vaccine Sales Price Analysis
        5.1.4 North America  23-Valent Pneumococcal Polysaccharide Vaccine Market Share Analysis
    5.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Analysis
        5.2.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Overview
        5.2.2 Europe -E 23-Valent Pneumococcal Polysaccharide Vaccine Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 Europe -E 23-Valent Pneumococcal Polysaccharide Vaccine Sales Price Analysis
        5.2.4 Europe  23-Valent Pneumococcal Polysaccharide Vaccine Market Share Analysis
    5.3 China 23-Valent Pneumococcal Polysaccharide Vaccine Market Analysis
        5.3.1 China 23-Valent Pneumococcal Polysaccharide Vaccine Market Overview
        5.3.2 China -E 23-Valent Pneumococcal Polysaccharide Vaccine Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 China -E 23-Valent Pneumococcal Polysaccharide Vaccine Sales Price Analysis
        5.3.4 China  23-Valent Pneumococcal Polysaccharide Vaccine Market Share Analysis
    5.4 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market Analysis
        5.4.1 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market Overview
        5.4.2 Japan -E 23-Valent Pneumococcal Polysaccharide Vaccine Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Japan -E 23-Valent Pneumococcal Polysaccharide Vaccine Sales Price Analysis
        5.4.4 Japan  23-Valent Pneumococcal Polysaccharide Vaccine Market Share Analysis
    5.5 Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Market Analysis
        5.5.1 Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Market Overview
        5.5.2 Southeast Asia -E 23-Valent Pneumococcal Polysaccharide Vaccine Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Southeast Asia -E 23-Valent Pneumococcal Polysaccharide Vaccine Sales Price Analysis
        5.5.4 Southeast Asia  23-Valent Pneumococcal Polysaccharide Vaccine Market Share Analysis
    5.6 India 23-Valent Pneumococcal Polysaccharide Vaccine Market Analysis
        5.6.1 India 23-Valent Pneumococcal Polysaccharide Vaccine Market Overview
        5.6.2 India -E 23-Valent Pneumococcal Polysaccharide Vaccine Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India -E 23-Valent Pneumococcal Polysaccharide Vaccine Sales Price Analysis
        5.6.4 India  23-Valent Pneumococcal Polysaccharide Vaccine Market Share Analysis

6 Global -E 23-Valent Pneumococcal Polysaccharide Vaccine Segment Market Analysis (by Type)
    6.1 Global -E 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
    6.2 Different Types of 23-Valent Pneumococcal Polysaccharide Vaccine Product Interview Price Analysis
    6.3 Different Types of 23-Valent Pneumococcal Polysaccharide Vaccine Product Driving Factors Analysis
        6.3.1 Single Dose Vial Growth Driving Factor Analysis
        6.3.2 Pre-filled Syringe Growth Driving Factor Analysis

7 Global -E 23-Valent Pneumococcal Polysaccharide Vaccine Segment Market Analysis (by Application)
    7.1 Global -E 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application
    7.2 Different Application of 23-Valent Pneumococcal Polysaccharide Vaccine Product Interview Price Analysis
    7.3 Different Application of 23-Valent Pneumococcal Polysaccharide Vaccine Product Driving Factors Analysis
        7.3.1 For Children (2-10) of 23-Valent Pneumococcal Polysaccharide Vaccine Growth Driving Factor Analysis
        7.3.2 For Person (10-64) of 23-Valent Pneumococcal Polysaccharide Vaccine Growth Driving Factor Analysis
        7.3.3 For The Old (?65) of 23-Valent Pneumococcal Polysaccharide Vaccine Growth Driving Factor Analysis

8 Major Manufacturers Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
    8.1 MSD
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 MSD  23-Valent Pneumococcal Polysaccharide Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 MSD  23-Valent Pneumococcal Polysaccharide Vaccine Business Region Distribution Analysis
    8.2 Sanofipasteur
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 Sanofipasteur  23-Valent Pneumococcal Polysaccharide Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Sanofipasteur  23-Valent Pneumococcal Polysaccharide Vaccine Business Region Distribution Analysis
    8.3 CDIBP
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 CDIBP  23-Valent Pneumococcal Polysaccharide Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 CDIBP  23-Valent Pneumococcal Polysaccharide Vaccine Business Region Distribution Analysis

9 Development Trend of Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine Market
    9.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Trend Analysis
        9.1.1 Global -2025 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (Volume and Value) Forecast
        9.1.2 Global -2025 23-Valent Pneumococcal Polysaccharide Vaccine Sales Price Forecast
    9.2 23-Valent Pneumococcal Polysaccharide Vaccine Regional Market Trend
        9.2.1 North America -2025 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast
        9.2.2 Europe -2025 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast
        9.2.3 China -2025 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast
        9.2.4 Japan -2025 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast
        9.2.5 Southeast Asia -2025 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast
        9.2.6 India -2025 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast
    9.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Trend (Product Type)
    9.4 23-Valent Pneumococcal Polysaccharide Vaccine Market Trend (Application)

10 23-Valent Pneumococcal Polysaccharide Vaccine Marketing Type Analysis
    10.1 23-Valent Pneumococcal Polysaccharide Vaccine Regional Marketing Type Analysis
    10.2 23-Valent Pneumococcal Polysaccharide Vaccine International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of 23-Valent Pneumococcal Polysaccharide Vaccine by Region
    10.4 23-Valent Pneumococcal Polysaccharide Vaccine Supply Chain Analysis

11 Consumers Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Professional Survey Report
    Methodology
    Analyst Introduction
    Data Source
List of Tables and Figures
    Figure Picture of 23-Valent Pneumococcal Polysaccharide Vaccine
    Table Product Specifications of 23-Valent Pneumococcal Polysaccharide Vaccine
    Table Classification of 23-Valent Pneumococcal Polysaccharide Vaccine
    Figure Global Production Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type in
    Figure Single Dose Vial Picture
    Table Major Manufacturers of Single Dose Vial
    Figure Pre-filled Syringe Picture
    Table Major Manufacturers of Pre-filled Syringe
    Table Applications of 23-Valent Pneumococcal Polysaccharide Vaccine
    Figure Global Consumption Volume Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Application in
    Figure For Children (2-10) Examples
    Table Major Consumers in For Children (2-10)
    Figure For Person (10-64) Examples
    Table Major Consumers in For Person (10-64)
    Figure For The Old (?65) Examples
    Table Major Consumers in For The Old (?65)
    Figure Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Regions
    Figure North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (Million USD) (-2025)
    Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (Million USD) (-2025)
    Figure China 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (Million USD) (-2025)
    Figure Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (Million USD) (-2025)
    Figure Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (Million USD) (-2025)
    Figure India 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (Million USD) (-2025)
    Table 23-Valent Pneumococcal Polysaccharide Vaccine Raw Material and Suppliers
    Table Manufacturing Cost Structure Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine in
    Figure Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
    Figure Industry Chain Structure of 23-Valent Pneumococcal Polysaccharide Vaccine
    Table Capacity and Commercial Production Date of Global 23-Valent Pneumococcal Polysaccharide Vaccine Major Manufacturers in
    Table Manufacturing Plants Distribution of Global 23-Valent Pneumococcal Polysaccharide Vaccine Major Manufacturers in
    Table R&D Status and Technology Source of Global 23-Valent Pneumococcal Polysaccharide Vaccine Major Manufacturers in
    Table Raw Materials Sources Analysis of Global 23-Valent Pneumococcal Polysaccharide Vaccine Major Manufacturers in
    Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of 23-Valent Pneumococcal Polysaccharide Vaccine -E
    Figure Global -E 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (Volume) and Growth Rate
    Figure Global -E 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (Value) and Growth Rate
    Table -E Global 23-Valent Pneumococcal Polysaccharide Vaccine Capacity and Growth Rate
    Table  Global 23-Valent Pneumococcal Polysaccharide Vaccine Capacity (K Dose) List (Company Segment)
    Table -E Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) and Growth Rate
    Table  Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) List (Company Segment)
    Table -E Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Price (USD/Dose)
    Table  Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Price (USD/Dose) List (Company Segment)
    Figure North America Capacity Overview
    Table North America Supply, Import, Export and Consumption (K Dose) of 23-Valent Pneumococcal Polysaccharide Vaccine -E
    Figure North America -E 23-Valent Pneumococcal Polysaccharide Vaccine Sales Price (USD/Dose)
    Figure North America  23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share
    Figure Europe Capacity Overview
    Table Europe Supply, Import, Export and Consumption (K Dose) of 23-Valent Pneumococcal Polysaccharide Vaccine -E
    Figure Europe -E 23-Valent Pneumococcal Polysaccharide Vaccine Sales Price (USD/Dose)
    Figure Europe  23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share
    Figure China Capacity Overview
    Table China Supply, Import, Export and Consumption (K Dose) of 23-Valent Pneumococcal Polysaccharide Vaccine -E
    Figure China -E 23-Valent Pneumococcal Polysaccharide Vaccine Sales Price (USD/Dose)
    Figure China  23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share
    Figure Japan Capacity Overview
    Table Japan Supply, Import, Export and Consumption (K Dose) of 23-Valent Pneumococcal Polysaccharide Vaccine -E
    Figure Japan -E 23-Valent Pneumococcal Polysaccharide Vaccine Sales Price (USD/Dose)
    Figure Japan  23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share
    Figure Southeast Asia Capacity Overview
    Table Southeast Asia Supply, Import, Export and Consumption (K Dose) of 23-Valent Pneumococcal Polysaccharide Vaccine -E
    Figure Southeast Asia -E 23-Valent Pneumococcal Polysaccharide Vaccine Sales Price (USD/Dose)
    Figure Southeast Asia  23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share
    Figure India Capacity Overview
    Table India Supply, Import, Export and Consumption (K Dose) of 23-Valent Pneumococcal Polysaccharide Vaccine -E
    Figure India -E 23-Valent Pneumococcal Polysaccharide Vaccine Sales Price (USD/Dose)
    Figure India  23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share
    Table Global -E 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Type
    Table Different Types 23-Valent Pneumococcal Polysaccharide Vaccine Product Interview Price
    Table Global -E 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Application
    Table Different Application 23-Valent Pneumococcal Polysaccharide Vaccine Product Interview Price
    Table MSD Information List
    Table Product Overview
    Table  MSD 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD), Sales (K Dose), Ex-factory Price (USD/Dose)
    Figure  MSD 23-Valent Pneumococcal Polysaccharide Vaccine Business Region Distribution
    Table Sanofipasteur Information List
    Table Product Overview
    Table  Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD), Sales (K Dose), Ex-factory Price (USD/Dose)
    Figure  Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Business Region Distribution
    Table CDIBP Information List
    Table Product Overview
    Table  CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD), Sales (K Dose), Ex-factory Price (USD/Dose)
    Figure  CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Business Region Distribution
    Figure Global -2025 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (K Dose) and Growth Rate Forecast
    Figure Global -2025 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (Million USD) and Growth Rate Forecast
    Figure Global -2025 23-Valent Pneumococcal Polysaccharide Vaccine Sales Price (USD/Dose) Forecast
    Figure North America -2025 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Volume (K Dose) and Growth Rate Forecast
    Figure China -2025 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Volume (K Dose) and Growth Rate Forecast
    Figure Europe -2025 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Volume (K Dose) and Growth Rate Forecast
    Figure Southeast Asia -2025 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Volume (K Dose) and Growth Rate Forecast
    Figure Japan -2025 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Volume (K Dose) and Growth Rate Forecast
    Figure India -2025 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Volume (K Dose) and Growth Rate Forecast
    Table Global Sales Volume (K Dose) of 23-Valent Pneumococcal Polysaccharide Vaccine by Type -2025
    Table Global Consumption Volume (K Dose) of 23-Valent Pneumococcal Polysaccharide Vaccine by Application -2025
    Table Traders or Distributors with Contact Information of 23-Valent Pneumococcal Polysaccharide Vaccine by Region

Key Players

  • MSD (Merck & Co.)
  • Sanofi Pasteur
  • China National Biotec Group (CDIBP)
  • Pfizer Inc.
  • GlaxoSmithKline (GSK)
  • Seqirus (CSL Limited)
  • Serum Institute of India
  • Panacea Biotec
  • Shenzhen Kangtai Biological Products
  • Walvax Biotechnology
  • Bharat Biotech
  • Emergent BioSolutions

Market Segmentation

By Product Type

  • Single Dose Vial
  • Pre-filled Syringe

By Application

  • Children (2–10 years)
  • Adults (10–64 years)
  • Elderly (65+ years)

By Distribution Channel

  • Hospitals & Clinics
  • Public Health Programs
  • Pharmacies
  • Online Healthcare Platforms

By Region

  • North America
  • Europe
  • Asia-Pacific (China, India, Japan, South Korea, Australia, Southeast Asia)
  • Middle East & Africa
  • Central & South America

Regional Analysis

  • North America: Largest production hub, driven by Merck’s PPSV23 and strong immunization programs.
  • Europe: Sanofi Pasteur and GSK lead; demand supported by aging populations and government vaccination initiatives.
  • Asia-Pacific: China and India show rapid growth due to expanding healthcare infrastructure and government immunization drives.
  • South America: Brazil and Argentina are emerging markets with increasing vaccination coverage.
  • Middle East & Africa: Growth driven by WHO and UNICEF-supported immunization programs.

Porter’s Five Forces

  1. Threat of New Entrants – Low (high R&D costs, regulatory barriers).
  2. Bargaining Power of Suppliers – Moderate (specialized raw materials and biotech processes).
  3. Bargaining Power of Buyers – High (governments and health organizations negotiate bulk purchases).
  4. Threat of Substitutes – Moderate (conjugate vaccines like PCV13 compete in certain age groups).
  5. Industry Rivalry – High (few global players, intense competition in pricing and distribution).

FAQ's

Yes, we are providing all research support to get resolve all queries and concerns regarding the report. For all our clients.
Yes, we are providing complete customization in every report to fulfill your business needs.
Yes, we are providing regional and countries level analysis in the report, please mention the countries you are looking.
Yes, we are providing a discount for individuals and startups.
We offer access to more than one million market research reports. If the specific topic you need is not listed on our website, simply email us your requirements at [email protected]. Our research team will review your request and provide a customized report or the most relevant available study. We

Similar Reports

Product image
View
Chemicals & Materials

Polymer Membrane Market

$3250
Product image
View
Chemicals & Materials

Refinery Catalyst Market

$3050
Product image
View
Chemicals & Materials

High Performance Fluoropolymer Market

$3100
Product image
View
Chemicals & Materials

Organometallics Market

$3100